Resolian is a global laboratory contract research organization that provides bioanalytical and analytical sciences support for drug development, preclinical, and multi-regional clinical trials, emphasizing exceptional solutions and strong collaborative relationships. The company offers services in drug metabolism and pharmacokinetics and bioanalytical, new drugs, metabolites or generic drug assays, large molecule immunoassays, small molecule metabolite profiling and identification and biosimilar characterization, thereby assisting clients through the process of taking a drug from pre-clinical trials to market at earliest.

Why work with us

With a global presence in Australia, the US, the UK, and China, along with standardized SOPs and technologies, Resolian streamlines the transfer of validated assays throughout the drug development process—significantly reducing costs and complexity for the sponsor.